Annual D&A
$2.47 M
+$923.00 K+59.70%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual depreciation & amortization is $2.47 million, with the most recent change of +$923.00 thousand (+59.70%) on December 31, 2023.
- During the last 3 years, STOK annual D&A has risen by +$1.58 million (+178.04%).
- STOK annual D&A is now at all-time high.
Performance
STOK Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$540.00 K
-$8000.00-1.46%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly depreciation & amortization is $540.00 thousand, with the most recent change of -$8000.00 (-1.46%) on September 30, 2024.
- Over the past year, STOK quarterly D&A has dropped by -$97.00 thousand (-15.23%).
- STOK quarterly D&A is now -15.23% below its all-time high of $637.00 thousand, reached on September 30, 2023.
Performance
STOK Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.27 M
-$97.00 K-4.09%
September 30, 2024
Summary
- As of February 7, 2025, STOK TTM depreciation & amortization is $2.27 million, with the most recent change of -$97.00 thousand (-4.09%) on September 30, 2024.
- Over the past year, STOK TTM D&A has dropped by -$179.00 thousand (-7.29%).
- STOK TTM D&A is now -7.86% below its all-time high of $2.47 million, reached on December 31, 2023.
Performance
STOK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
STOK Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.7% | -15.2% | -7.3% |
| 3 y3 years | +178.0% | -15.2% | -7.3% |
| 5 y5 years | +1053.7% | -15.2% | -7.3% |
STOK Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +153.5% | -15.2% | +129.8% | -7.9% | +133.6% |
| 5 y | 5-year | at high | +448.7% | -15.2% | +288.5% | -7.9% | +405.6% |
| alltime | all time | at high | +2085.0% | -15.2% | +1587.5% | -7.9% | +7009.4% |
Stoke Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $540.00 K(-1.5%) | $2.27 M(-4.1%) |
| Jun 2024 | - | $548.00 K(-2.7%) | $2.37 M(-2.6%) |
| Mar 2024 | - | $563.00 K(-9.8%) | $2.44 M(-1.4%) |
| Dec 2023 | $2.47 M(+59.7%) | $624.00 K(-2.0%) | $2.47 M(+0.6%) |
| Sep 2023 | - | $637.00 K(+4.3%) | $2.45 M(+11.3%) |
| Jun 2023 | - | $611.00 K(+2.3%) | $2.21 M(+16.3%) |
| Mar 2023 | - | $597.00 K(-2.0%) | $1.90 M(+22.6%) |
| Dec 2022 | $1.55 M(+58.7%) | $609.00 K(+57.0%) | $1.55 M(+31.9%) |
| Sep 2022 | - | $388.00 K(+28.5%) | $1.17 M(+12.9%) |
| Jun 2022 | - | $302.00 K(+22.3%) | $1.04 M(+5.4%) |
| Mar 2022 | - | $247.00 K(+5.1%) | $985.00 K(+1.1%) |
| Dec 2021 | $974.00 K | $235.00 K(-7.5%) | $974.00 K(-0.2%) |
| Sep 2021 | - | $254.00 K(+2.0%) | $976.00 K(+2.1%) |
| Jun 2021 | - | $249.00 K(+5.5%) | $956.00 K(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $236.00 K(-0.4%) | $931.00 K(+4.8%) |
| Dec 2020 | $888.00 K(+97.3%) | $237.00 K(+1.3%) | $888.00 K(+12.4%) |
| Sep 2020 | - | $234.00 K(+4.5%) | $790.00 K(+15.8%) |
| Jun 2020 | - | $224.00 K(+16.1%) | $682.00 K(+21.1%) |
| Mar 2020 | - | $193.00 K(+38.8%) | $563.00 K(+25.1%) |
| Dec 2019 | $450.00 K(+110.3%) | $139.00 K(+10.3%) | $450.00 K(+16.6%) |
| Sep 2019 | - | $126.00 K(+20.0%) | $386.00 K(+19.1%) |
| Jun 2019 | - | $105.00 K(+31.3%) | $324.00 K(+23.7%) |
| Mar 2019 | - | $80.00 K(+6.7%) | $262.00 K(+22.4%) |
| Dec 2018 | $214.00 K(+89.4%) | $75.00 K(+17.2%) | $214.00 K(+54.0%) |
| Sep 2018 | - | $64.00 K(+48.8%) | $139.00 K(+85.3%) |
| Jun 2018 | - | $43.00 K(+34.4%) | $75.00 K(+134.4%) |
| Mar 2018 | - | $32.00 K | $32.00 K |
| Dec 2017 | $113.00 K | - | - |
FAQ
- What is Stoke Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Stoke Therapeutics?
- What is Stoke Therapeutics annual D&A year-on-year change?
- What is Stoke Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly D&A year-on-year change?
- What is Stoke Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Stoke Therapeutics?
- What is Stoke Therapeutics TTM D&A year-on-year change?
What is Stoke Therapeutics annual depreciation & amortization?
The current annual D&A of STOK is $2.47 M
What is the all time high annual D&A for Stoke Therapeutics?
Stoke Therapeutics all-time high annual depreciation & amortization is $2.47 M
What is Stoke Therapeutics annual D&A year-on-year change?
Over the past year, STOK annual depreciation & amortization has changed by +$923.00 K (+59.70%)
What is Stoke Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of STOK is $540.00 K
What is the all time high quarterly D&A for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly depreciation & amortization is $637.00 K
What is Stoke Therapeutics quarterly D&A year-on-year change?
Over the past year, STOK quarterly depreciation & amortization has changed by -$97.00 K (-15.23%)
What is Stoke Therapeutics TTM depreciation & amortization?
The current TTM D&A of STOK is $2.27 M
What is the all time high TTM D&A for Stoke Therapeutics?
Stoke Therapeutics all-time high TTM depreciation & amortization is $2.47 M
What is Stoke Therapeutics TTM D&A year-on-year change?
Over the past year, STOK TTM depreciation & amortization has changed by -$179.00 K (-7.29%)